Weight loss moderately greater with 4:3 IMF versus daily calorie restriction in adults with overweight, obesity<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b>
\n<\/b><\/p>\n
MONDAY, March 31, 2025 (HealthDay News) — An intermittent fasting (IMF) intervention yields modestly greater weight loss than daily caloric restriction (DCR) among adults with overweight or obesity, according to a study published online April 1 in the Annals of Internal Medicine<\/em>.<\/p>\n Victoria A. Catenacci, M.D., from the University of Colorado Anschutz Medical Campus in Aurora, and colleagues compared the effects of 4:3 IMF versus DCR on changes in weight at 12 months with comprehensive behavioral support in a randomized clinical trial involving adults aged 18 to 60 years with a body mass index of 27 to 46 kg\/m2<\/sup>. The IMF group was instructed to restrict energy intake by 80 percent on three nonconsecutive days per week, with no restriction on the other four days (4:3 IMF). The DCR group was instructed to match the weekly energy deficit by reducing daily energy intake by 34 percent. Both groups also received a high-intensity comprehensive behavioral weight loss program.<\/p>\n The study included 165 participants: 84 4:3 IMF and 81 DCR; 125 individuals completed the trial. The researchers found that at 12 months, 4:3 IMF showed greater reductions in weight than DCR in an intention-to-treat analysis (mean difference, 2.89 kg).<\/p>\n “4:3 IMF should be considered within the range of evidence-based dietary weight loss approaches,” the authors write.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n